THE ALVEON SMART DOSE VAPORISATION PLATFORM (SDV).
A patented ceramic dosing technology for metered-dose inhalation of phytopharmaceuticals and bio-based medicines. Developed by inhalation industry experts and aerospace engineers. Designed for EU MDR Class II certification.
BASICS
The lung as a therapeutic delivery pathway.
A healthy lung contains approximately 300 million alveoli, providing a total surface area of around 120,000 cm² in direct contact with the circulatory system. This makes the pulmonary route one of the most efficient pathways for systemic drug delivery: inhaled active ingredients reach the bloodstream rapidly, bypassing first-pass hepatic metabolism and enabling precise dose-response relationships.
​
Pulmonary drug delivery is already established for a wide range of respiratory and systemic conditions. More than 400 active ingredients are considered suitable for thermal vaporisation, underscoring the broad therapeutic potential of inhalation as a delivery modality.
300.000.000
ALVEOLI
120.000
CM² OF ACCESS TO OUR SYSTEM
400+
MEDICATIONS SUITABLE FOR THERMAL EVAPORATION
PATENTED TECHNOLOGY
Ceramic dosing technology. Engineered for pharmaceutical precision.
The Alveon SDV platform is built around a patented ceramic thermal vaporisation mechanism that enables precise control over vaporisation temperature, particle size distribution, and aerosol characteristics. This level of process control is a prerequisite for reproducible pharmacokinetic profiles and the foundation of pharmaceutical-grade device certification.
​
The platform is substance-agnostic: the core dosing engine can be adapted for a broad range of plant-based and phytopharmaceutical active ingredients.
​
Alveon's intellectual property covers every critical component of the SDV platform.
Protected by core patents with international coverage:
REGULATORY
Developed for regulatory approval.
The Alveon SDV platform is being developed in full alignment with the EU Medical Device Regulation (EU MDR) Class II certification pathway.
Device development, documentation, and quality management follow the standards required for prescription-grade medical devices, supporting clinical application, pharmacy distribution, and reimbursement across the European market.